Constructing biomimetic liver models through biomaterials and vasculature engineering
Open accessThe DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.
Abstract
The occurrence of various liver diseases can lead to organ failure of the liver, which is one of the leading causes of mortality worldwide. Liver tissue engineering see the potential for replacing liver transplantation and drug toxicity studies facing donor shortages. The basic elements in liver tissue engineering are cells and biomaterials. Both mature hepatocytes and differentiated stem cells can be used as the main source of cells to construct spheroids and organoids, achieving improved cell function. To mimic the extracellular matrix (ECM) environment, biomaterials need to be biocompatible and bioactive, which also help support cell proliferation and differentiation and allow ECM deposition and vascularized structures formation. In addition, advanced manufacturing approaches are required to construct the extracellular microenvironment, and it has been proved that the structured three-dimensional culture system can help to improve the activity of hepatocytes and the characterization of specific proteins. In summary, we review biomaterials for liver tissue engineering, including natural hydrogels and synthetic polymers, and advanced processing techniques for building vascularized microenvironments, including bioassembly, bioprinting and microfluidic methods. We then summarize the application fields including transplant and regeneration, disease models and drug cytotoxicity analysis. In the end, we put the challenges and prospects of vascularized liver tissue engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 3. Biomaterials used in the vascularized liver tissue engineering. (a) Pluronic and alginate with high applicability. Adapted with permission from Ref. [140]. (b) Collagen type I with hyaluronic acid. Adapted with permission from Ref. [149]. (c) Gelatin. (ci) Gelatin scaffolds. Adapted with permission from Ref. [71]. (cii) Photocrosslinking of GelMA, producing vascularized tissues with complex shapes. Adapted with permission from Ref. [147]. (d) dECM bioink with enhanced printability and mechanical properties. Adapted with permission from Ref. [151]. (e) Synthetic polymers. (ei) PCL mixed with biodegradable hollow fibers (HF). Adapted with permission from Ref. [156]. (eii) PLGA scaffolds. Adapted with permission from Ref. [157]. (f) Cellulose nanocrystals (CNC). Adapted with permission from Ref. [164].](https://figures.cochat.ai/paper-figures/b5f1bda8892848f788cb53e461fcdefa/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-3.jpg)
![Figure 4. Bioprinted vascularized liver models. (a) Inkjet-based bioprinting. Adapted with permission from Ref. [177]. (b) Photocuring-based bioprinting. Adapted with permission from Ref. [189]. (c) Extrusion-based bioprinting. (ci) Pre-set micro-extrusion printing. Adapted with permission from Ref. [102]. (cii) Coaxial extrusion printing. Adapted with permission from Ref. [67]. (ciii, civ) Sacrificial printing. Adapted with permission from Ref. [69, 187]. (d) Microvascular induction. (di) Microvascular induction to generate liver organoids. Adapted with permission from Ref. [103]. (dii) Microvascular induction to generate hepatic spheroids. Adapted with permission from Ref. [196].](https://figures.cochat.ai/paper-figures/42ae5d0d25a348528d9203faa4703046/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-4.jpg)
![Figure 5. Microfluidics-based vascularized liver models. (a) Liver sinusoidal fold chip. Adapted with permission from Ref. [30]. (b) Bionic liver lobule chip. Adapted with permission from Ref. [199]. (c) Fluid-coupled multiorgan chip. Adapted with permission from Ref. [201]. (d) Nonalcoholic fatty liver organ chip. Adapted with permission from Ref. [202].](https://figures.cochat.ai/paper-figures/ae37ff4fb61347ab87c782bbf9e1c64a/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-5.jpg)
![Figure 6. Applications of vascularized liver tissue. (a) Transplanted liver tissue into the liver-injured rats. Adapted with permission from Ref. [75]. (b) Drug cytotoxicity analysis. (bi) Vascularized hepatic lobular organoids for drug cytotoxicity analysis. Adapted with permission from Ref. [170]. (bii) Mechanism of action of several known hepatotoxic drugs and one experimental compound. Adapted with permission from Ref. [66]. (c) Disease models. (ci) Liver fibrosis model. Adapted with permission from Ref. [82] (cii) Cancer model [209]. (ciii) Virus transfection model. Adapted with permission from Ref. [210].](https://figures.cochat.ai/paper-figures/a5e114b550204469ab921fdad6801cdc/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, drug treatments may alleviate symptoms and slow disease progression but cannot fundamentally restore liver function [20–23].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels
Yue, K., Trujillo-de Santiago, G., Alvarez, M. M., Tamayol, A., Annabi, N., & Khademhosseini, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.045 · Cited by 3,146 · cited 2×
“Gelatin Methacrylamide (GelMA) is a modified gelatin that crosslinks in seconds under UV light [133, 145].”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 2×
“Under pathological conditions, adipocytes are activated and abnormally proliferate, producing ECM and increasing intrahepatic fibrosis, which can finally lead to cirrhosis [110, 115, 116].”
BackgroundVascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“great importance to reconstruct the unique liver vasculature system [9, 10].”
BackgroundMatrigel: Basement membrane matrix with biological activity
Kleinman, H. K., & Martin, G. R. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.004 · Cited by 1,673
Matrigel: A complex protein mixture required for optimal growth of cell culture
Hughes, C. S., Postovit, L. M., & Lajoie, G. A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900758 · Cited by 1,534 · cited 1×
“Matrigel is a biomaterial that regulates the cellular microenvironment and contains various components such as cohesin, collagen IV, fibronectin and heparan sulfate [159, 160].”
BackgroundThree-dimensional bioprinting of thick vascularized tissues
Kolesky, D. B., Homan, K. A., Skylar-Scott, M. A., & Lewis, J. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521342113 · Cited by 1,492
Multivascular networks and functional intravascular topologies within biocompatible hydrogels
Grigoryan, B., Paulsen, S. J., Corbett, D. C., Sazer, D. W., Fortin, C. L., Zaita, A. J., Greenfield, P. T., Calafat, N. J., Gounley, J. P., Ta, A. H., et al. (2019) · Science · doi:10.1126/science.aav9750 · Cited by 1,396
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Research works printed but not linked: 1
- He, 2016, Research on the printability of hydrogels in 3D bioprinting, Sci Rep, 6, 29977, 10.1038/srep29977 · DOI · Paper page
Cited by
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Huang, Y., Liu, T., Huang, Q., & Wang, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00004 · Cited by 109
Self-citationLi, C., An, N., Song, Q., Hu, Y., Yin, W., Wang, Q., Le, Y., Pan, W., Yan, X., Wang, Y., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01086-7 · Cited by 67
“Furthermore, the extracellular matrix can effectively retain an array of bioactive substances, including cytokines and glycosaminoglycans, which also furnishes a viable experimental concept and foundation for the in vitro emulation of organ or cell interactions from disparate sources [136].”
BackgroundRecent progress of 3D printed vascularized tissues and organs
Zheng, K., Chai, M., Luo, B., Cheng, K., Wang, Z., Li, N., & Shi, X. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.01.001 · Cited by 60
3D printing for tissue/organ regeneration in China
He, C., He, J., Wu, C., Ruan, C., Gu, Q., Hao, Y., Wu, Y. B., Bai, S., Han, X., Ouyang, L., et al. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2400309 · Cited by 48
Self-citationLiver Organoids as an In Vitro Model to Study Primary Liver Cancer
Siervi, S. D., & Turato, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054529 · Cited by 35
Luo, S., Wang, Q., Li, M., Xu, P., Wang, Y., Wang, Y., Kankala, R. K., Wang, S., & Chen, A. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbae113 · Cited by 23
“For instance, liver-derived dECM has been enzymatically digested to create thermosensitive hydrogels, combined with other hydrogels such as GelMA or hyaluronic acid [17–19].”
MethodFritschen, A., Mestre, M. A., Scholpp, S., & Blaeser, A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1093101 · Cited by 21
“They are robust cell line, greatly available and simple to culture (Müsch et al., 2020; Štampar et al., 2020; Kammerer, 2021; Lv et al., 2022), making them the most widely used hepatoma cell line (Donato et al.”
BackgroundNair, D. G., & Weiskirchen, R. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb46010018 · Cited by 22
“Several studies carried out using modified collagen for liver tissue engineering showed positive outcomes with the expression of hepatic markers of cell spheroids [26].”
BackgroundInfluential3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation
Yan, J., Ye, Z., Lu, Y., Yuan, Y., Wang, X., Yan, T., Yin, J., & Wang, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101515 · Cited by 15
Qassab, M. A., Merheb, M., Sayadi, S., Salloum, P., Dabbousi, Z., Bayeh, A., Harb, F., Azar, S. T., & Ghadieh, H. E. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16100356 · Cited by 18
Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering
Xu, K., Zhang, Q., Zhu, D., & Jiang, Z. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300577 · Cited by 17
Biomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration
Wang, J., Huang, D., Ren, H., & Zhao, Y. (2025) · Advanced Science · doi:10.1002/advs.202405662 · Cited by 13
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
Liu, X., Shi, X., Zhang, D., Zhao, S., Hu, J., Ouyang, Q., Yin, J., Yao, X., Zhang, Y., & Yan, L. (2025) · Composites Part B Engineering · doi:10.1016/j.compositesb.2025.112260 · Cited by 12
Hydrogel-Based Vascularized Organ Tissue Engineering: A Systematized Review on Abdominal Organs
Karageorgos, F. F., Alexiou, M. V., Tsoulfas, G., & Alexopoulos, A. H. (2024) · Gels · doi:10.3390/gels10100653 · Cited by 10
“Additional interesting reviews include the use of biomaterials for vasculature engineering to construct liver tissue from Lv et al. [31] or include various biomaterials to promote vascularization in organ tissue engineering from Zhao et al. [32].”
BackgroundLindberg, G., Norberg, A. E., Soliman, B., Jüngst, T., Lim, K. S., Hooper, G. J., Gröll, J., & Woodfield, T. B. F. (2024) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2024.1331032 · Cited by 9
Zhu, L., Liu, S., Yang, Z., Yang, L., Yang, Y., Han, P., Yu, M., Lin, L., Xu, L., Li, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.04.030 · Cited by 22
“For the construction of liver microtissues, the functionality and availability of seed cells play a key role in determining the function and behavior of grafts in vitro and in vivo [31].”
Self-citationShagidulin, M. Y., Онищенко, Н. А., Sevastianov, V. I., Крашенинников, М. Е., Lyundup, A. V., Nikolskaya, A. O., Kryzhanovskaya, A., Voznesenskaia, S., Gorelova, M., Perova, N. V., et al. (2023) · Gels · doi:10.3390/gels9060456 · Cited by 10
Iohexol as a refractive index tuning agent for bioinks in high cell density bioprinting
Xiang, Y., Sun, Y., Guan, J., Meng‐Saccoccio, T., Lu, T.-Y., Berry, D. B., & Chen, S. (2025) · Biomaterials Science · doi:10.1039/d5bm00585j · Cited by 8
Kumari, K., Sanyal, A., Rawat, P., Kumar, V., Garg, M., Lahiri, D., Ghosh, S., & Baligar, P. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00350 · Cited by 8
Lv, W., Yu, H., Aazmi, A., Naren, T., Cheng, W., Yu, M., Wang, Z., Xu, X., Yang, H., & Ma, L. (2025) · International Journal of Extreme Manufacturing · doi:10.1088/2631-7990/ada836 · Cited by 11
Self-citationNah, H., Michell, A. R., Rogy, K. M., Lally, O. J., & Khetani, S. R. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115737 · Cited by 11
Design principles of adhesive hydrogels for biomedical application
Tan, Z., Song, W., & Li, R. (2026) · Materials Horizons · doi:10.1039/d5mh01933h · Cited by 7
Sanyal, A., & Ghosh, S. (2024) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2024.100526 · Cited by 9
Liver-on-a-Chip (LoC) Models: Case Studies of Academic Platforms and Commercial Products
Benzait, Z., Tomsuk, Ö., Ebrahimi, A., Ghorbanpoor, H., Özel, C., Didarian, R., Cevizlidere, B. D., Kaya, M., Gür, T., Gasimzade, N., et al. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01122 · Cited by 7
“30 − 33 The liver sinusoidal endothelial cells (LSECs) lining the walls of sinusoids facilitate the transfer of substances between the blood and HCs.”
InfluentialSekar, J. A., Velayudhan, S., Senthilkumar, M., & Kumar, P. R. A. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114272 · Cited by 5
Nguyen, C.-T., Le, V. P., Le, T. H., Kim, J. S., Back, S. H., & Koo, K.-I. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16010035 · Cited by 5
Construction, evaluation, and applications of renal barrier-on-a-chip system
Naren, T., Lv, W., Aazmi, A., Wang, Y., Yu, H., Lee, J. Y., Yang, H., Yu, M., Jiang, X., Yang, H., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.032 · Cited by 4
Self-citationComplex in vitro models: do not complicate it
Oliveira, J. M. (2023) · In vitro models · doi:10.1007/s44164-023-00060-1 · Cited by 4
“From the materials science and engineering point of view, the most promising technologies for the production of ECM-dependent CIVMs include advanced biomaterials and formulations [5, 6], and bioinks [7] to be used in biofabrication methods [8].”
Lv, W., Naren, T., Aazmi, A., Yu, H., Wang, Y., Lee, J. Y., Yu, M., Jia, J., Jiang, X., Yang, H., et al. (2026) · Advanced Materials · doi:10.1002/adma.202513401 · Cited by 5
Self-citationPai, R. R., Muthusamy, S., Velayudhan, S., & Anil Kumar, P. R. (2025) · Biofabrication · doi:10.1088/1758-5090/ae302d · Cited by 2
Hard tissue organoids: From concept to practice
Xu, X., Zhang, W., Qian, J., Gu, X., Fan, S., Niu, Q., Reis, R. L., Kundu, S. C., Yao, X., & Zhang, Y. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.04.014 · Cited by 2
Self-citationAugmented in vitro liver models with bioprinted liver organoids
Congress, Z., Huh, J., Yoo, J. J., Lee, S. J., & Söker, S. (2024) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2024.100531 · Cited by 1
Li, M., Zhou, Y. X., Chen, X., Yue, Z., Winberg, P. C., & Wallace, G. G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146461 · Cited by 1
Biomimetic injectable hydrogels of gelatin and hyaluronic acid for hepatic cell culture
Rodríguez-Fernández, J. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/207128
Biomaterials in the fabrication of artificial tissues
haq, F. U., & Roopavath, U. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32828-2.00007-7
Advances in 3D-bioprinted implantable liver microtissue for liver failure treatment
Lin, Y., Huang, Y., Cheng, D., Li, M., & Tao, Y. (2026) · Chemical Communications · doi:10.1039/d6cc03265f
Self-citationHuman placenta extract declines fat deposition in an in vitro novel 3D MASLD model
Taheri, P., Majidi, F., Nouri, K., Nouri, M., Zarrabi, M., Rismani, E., Piryaei, A., & Vosough, M. (2026) · In vitro models · doi:10.1007/s44164-026-00142-w
From nanoengineering to microphysiology: Organ-on-chip platforms for next-generation drug delivery
Akar, Ü., Kestek, E., Çelik, İ., Kozalak, G., & Koşar, A. (2026) · Biophysics Reviews · doi:10.1063/5.0332911
3D Liver Fibrosis Models in Lab: A Novel Modality for Drug Screening
Alikhani, H. K., Majidi, F., Ghasemzad, M., Shpichka, A. I., Nestorova, A., Hendi, Z., Rismani, E., Kuznetsova, D. S., Timashev, P., Vosough, M., et al. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70306
“Due to the self-organizing and self-regenerating properties of liver organoids, they can be used for injury repair, liver regeneration, and transplantation [166].”
Liver‐on‐Chip Models as Miniaturized Platforms for In Vitro Hepatotoxicity Testing
Sahoo, S., & Bishi, D. K. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70435
A review of biomaterials and artificial organs development
Khan, S., & Rahman, J. S. U. (2026) · Asian Journal of Science Engineering and Technology (AJSET) · doi:10.47264/idea.ajset/5.1.6
Zhu, X., Feng, H., Zhou, Y., Deng, Y., Li, L., Li, Y., Yang, Y., Liu, P., Liang, Z., Li, Y., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124721
Metadata
- Authors
- Lv, W., Zhou, H., Aazmi, A., Yu, M., Xu, X., Yang, H., Huang, Y. Y. S., & Ma, L.
- Affiliations
- State Key Laboratory Fluid Power and Mechatronic Systems (CN)
- Zhejiang University Medical College Affiliated Stomatological Hospital (CN)
- Tongji University (CN)
- University of Cambridge (GB)
- Corresponding author
- Ma, Liang
- ORCID
- Venue
- Regenerative Biomaterials
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-01-01
- Volume
- 9
- Pages
- rbac079-rbac079
- ISSN
- 2056-3418 (ISSN-L)
- 2056-3426
- PMC
- PMC9629974
- OpenAlex
- W4304807955
- Cited by
- 45
- References
- 215
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 14 · 2023: 5
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Regenerative Biomaterials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Natural Science Foundation of China (51875518, 52105310, 52275294, 2018YFA0703000)
- National Key Research and Development Program of China (2018YFA0703000, 51875518)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- liver tissue engineering, biomaterials, hepatocytes, stem cells, extracellular matrix, hydrogels, synthetic polymers, bioprinting, microfluidics, liver regeneration, liver transplantation, disease models, drug toxicity testing, vascularization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.